DIPLOMAT PHARMACY INC.
DIPLOMAT PHARMACY INC.
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: DPLO
ISIN:

DIPLOMAT PHARMACY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

  • 80
DIPLOMAT PHARMACY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

PR Newswire

NEW ORLEANS, March 1, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc. (NYSE: DPLO), if they purchased the Company's securities between February 26, 2018 and February 21, 2019, inclusive (the "Class Period").  This action is pending in the United States District Court for the Central District of California.

Kahn Swick & Foti, LLC ("KSF") - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto/Kahn Swick & Foti, LLC)

What You May Do

If you purchased securities of Diplomat and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-dplo/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by April 25, 2019.

About the Lawsuit

Diplomat and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On February 22, 2019, Diplomat disclosed the postponement of the release of its Q4 and full-year 2018 earnings as it worked to finalize the amount of an impairment charge, which was "expected to be equal to a significant portion of the PBM's Goodwill and Definite-lived intangible assets, which total approximately $630 million as of December 31, 2018, prior to impairment charges."

On this news, the price of Diplomat's shares plummeted over 56%.

The case is Riehm v. Diplomat Pharmacy, Inc. et al, 19-cv-1369.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/diplomat-pharmacy-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick--foti-llc-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-diplomat-pharmacy-inc-300805145.html

SOURCE Kahn Swick & Foti, LLC

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.